Akanda Corp. (NASDAQ:AKAN – Get Free Report) was the target of a large decline in short interest in June. As of June 30th, there was short interest totaling 18,178 shares, a decline of 87.0% from the June 15th total of 139,841 shares. Based on an average trading volume of 44,335 shares, the short-interest ratio is currently 0.4 days. Approximately 4.2% of the shares of the stock are short sold.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on the stock. Wall Street Zen raised shares of Akanda to a “sell” rating in a research note on Saturday, May 30th. Weiss Ratings cut shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, May 18th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Akanda presently has an average rating of “Sell”.
Read Our Latest Analysis on Akanda
Akanda Stock Performance
Akanda (NASDAQ:AKAN – Get Free Report) last issued its quarterly earnings data on Tuesday, June 9th. The company reported ($317.90) earnings per share (EPS) for the quarter.
Akanda Company Profile
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Recommended Stories
- Five stocks we like better than Akanda
- AST SpaceMobile’s Next Launches Could Decide Whether Its Rally Regains Orbit
- 3 Dividend Stocks with Growth on Tap for the Second Half
- 3 Overlooked Stocks Positioned for the Next Market Rotation
- 3 Non-Tech Stocks Still Winning Big on AI
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
